Page 135 - IJB-9-4

International Journal of Bioprinting 3D bioprinted models in pediatric tumors

14. Tomayko MM, Reynolds CP, 1989, Determination of 25. Cobain EF, Wu YM, Vats P, et al., 2021, Assessment of
subcutaneous tumor size in athymic (nude) mice. Cancer clinical benefit of integrative genomic profiling in advanced
Chemother Pharmacol, 24(3):148–154. solid tumors.JAMA Oncol, 7(4):525–533.
https://doi.org/10.1007/BF00300234 https://doi.org/10.1001/jamaoncol.2020.7987
15. Hirabayashi K, Zamboni G, Nishi T, et al., 2013 Histopathology 26. Kapalczynska M, Kolenda T, Przybyla W, et al., 2018, 2D and
of gastrointestinal neuroendocrine neoplasms. Front 3D cell cultures—A comparison of different types of cancer
Oncol, 3:2. cell cultures. Arch Med Sci, 14(4):910–919.
https://doi.org/10.3389/fonc.2013.00002 https://doi.org/10.5114/aoms.2016.63743
16. Bownes LV, Williams AP, Marayati R, et al., 2021, 27. Stylianopoulos T, Jain RK, 2013, Combining two strategies
Serine-threonine kinase receptor-associated to improve perfusion and drug delivery in solid tumors.
protein (STRAP) knockout decreases the malignant Proc Natl Acad Sci U S A, 110(46):18632–18637.
phenotype in neuroblastoma cell lines. Cancers (Basel),
13(13):3201. https://doi.org/10.1073/pnas.1318415110
https://doi.org/10.3390/cancers13133201 28. Brown JM, Wilson WR, 2004, Exploiting tumour hypoxia in
cancer treatment. Nat Rev Cancer, 4(6):437–447.
17. Hockel M,Vaupel P, 2001, Biological consequences of tumor
hypoxia. Semin Oncol, 28(2 Suppl 8):36–41. https://doi.org/10.1038/nrc1367
https://www.ncbi.nlm.nih.gov/pubmed/11395851. 29. Bhandari V, Hoey C, Liu LY, et al., 2019, Molecular
landmarks of tumor hypoxia across cancer types. Nat Genet,
18. Jogi A, Ora I, Nilsson H, et al., 2002, Hypoxia alters gene
expression in human neuroblastoma cells toward an 51(2):308–318.
immature and neural crest-like phenotype. Proc Natl Acad https://doi.org/10.1038/s41588-018-0318-2
Sci U S A, 99(10):7021–7026.
30. Li Y, Li B, Li W, et al., 2020, Murine models of IDH-wild-type
https://doi.org/10.1073/pnas.102660199 glioblastoma exhibit spatial segregation of tumor initiation and
19. Braekeveldt N, Bexell D, 2018, Patient-derived xenografts manifestation during evolution. Nat Commun, 11(1):3669.
as preclinical neuroblastoma models. Cell Tissue Res, https://doi.org/10.1038/s41467-020-17382-3
372(2):233–243.
31. Braekeveldt N, von Stedingk K, Fransson S, et al., 2018,
https://doi.org/10.1007/s00441-017-2687-8
Patient-derived xenograft models reveal intratumor
20. Neel DV, Shulman DS, DuBois SG, 2019, Timing of first-in- heterogeneity and temporal stability in neuroblastoma.
child trials of FDA-approved oncology drugs. Eur J Cancer, Cancer Res, 78(20):5958–5969.
112:49–56.
https://doi.org/10.1158/0008-5472.CAN-18-0527
https://doi.org/10.1016/j.ejca.2019.02.011
32. Dong R, Yang R, Zhan Y, et al., 2020, Single-cell
21. Byron SA, Hendricks WPD, Nagulapally AB, et al., characterization of malignant phenotypes and
2021, Genomic and transcriptomic analysis of relapsed developmental trajectories of adrenal neuroblastoma.
and refractory childhood solid tumors reveals a diverse Cancer Cell, 38(5):716–733.e6.
molecular landscape and mechanisms of immune evasion.
Cancer Res, 81(23):5818–5832. https://doi.org/10.1016/j.ccell.2020.08.014
https://doi.org/10.1158/0008-5472.CAN-21-1033 33. Manas A, Aaltonen K, Andersson N, et al., 2022, Clinically
22. Aguirre AJ, Nowak JA, Camarda ND, et al., 2018, Real-time relevant treatment of PDX models reveals patterns of
genomic characterization of advanced pancreatic cancer to neuroblastoma chemoresistance.Sci Adv, 8(43):eabq4617.
enable precision medicine.Cancer Discov, 8(9):1096–1111. https://doi.org/10.1126/sciadv.abq4617
https://doi.org/10.1158/2159-8290.CD-18-0275 34. Pellegrini E, Desando G, Petretta M, et al., 2022, A 3D
23. Reda M, Richard C, Bertaut A, et al., 2020, Implementation collagen-based bioprinted model to study osteosarcoma
and use of whole exome sequencing for metastatic solid invasiveness and drug response. Polymers (Basel),
cancer. EBioMedicine, 51:102624. 14(19):4070.
https://doi.org/10.1016/j.ebiom.2019.102624 https://doi.org/10.3390/polym14194070
24. Murphy JM, Lim IIP, Farber BA, et al., 2016, Salvage rates 35. Tang M, Xie Q, Gimple RC, et al., 2020, Three-dimensional
after progression of high-risk neuroblastoma with a soft bioprinted glioblastoma microenvironments model
tissue mass. J Pediatr Surg, 51(2):285–288. cellular dependencies and immune interactions. Cell Res,
https://doi.org/10.1016/j.jpedsurg.2015.10.075 30(10):833–853.
https://doi.org/10.1038/s41422-020-0338-1

Volume 9 Issue 4 (2023) 127 https://doi.org/10.18063/ijb.723